Cytosorbents Corp Shares Close in on 52-Week Low - Market Mover
The shares closed 1.9% above its 52-week low of $4.25, with trading volume higher than its 30 day average
Dec 23, 2021 by Kwhen Finance Editors
Cytosorbents Corp (CTSO) shares closed today at 1.9% above its 52 week low of $4.25, giving the company a market cap of $188M. The stock is currently down 45.7% year-to-date, down 49.4% over the past 12 months, and down 19.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.3%.
Trading Activity
- Trading volume this week was 47.5% higher than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Cytosorbents Corp | 1.2 | -45.7 | -49.4 | ||
| Dow Jones Industrial Average | 0.7 | 18.9 | 21.1 | -2.6 | 20.8 |
| S&P 500 Index | 1.0 | 26.8 | 29.1 | -1.9 | 28.6 |
| Health Care | 1.0 | 21.9 | 23.8 | -1.1 | 24.6 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 2061.6%
- The company's stock price performance over the past 12 months lags the peer average by 1759.4%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Cytosorbents Corp | CTSO | 0 | -45.7 | -49.4 | ||
| Peer Avg | N/A | 10.8 | -2.1 | -2.7 | -8.1 | 8.1 |
| Boston Scientific Corp. | BSX | 53.2 | 14.4 | 18.1 | -11.3 | 20.0 |
| Hologic, Inc. | HOLX | 5.2 | 6.0 | 3.4 | ||
| Meridian Bioscience Inc. | VIVO | 6.1 | 8.2 | -3.9 | ||
| Nephros Inc | NEPH | 0 | -29.1 | -20.6 | ||
| Daxor Corporation | DXR | 0 | -12.2 | -12.9 | -37.1 | 28.8 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: